Cationic submicron emulsions overcome multidrug resistance in SGC7901/VCR cells

Pharmazie

Volumn 66, Issue 2, 2011, Pages 130-135

  Zhao, Yong Xing ^a,b   Liang, Wen Quan ^b   Wang, Ye ^c   Liu, Dan Xing ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAMPTOTHECIN DERIVATIVE; CATION; CATIONIC SUBMICRON EMULSION; DRUG VEHICLE; GLYCOPROTEIN P; HYDROXYCAMPTOTHECIN; RHODAMINE 123; UNCLASSIFIED DRUG; VERAPAMIL; NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; EMULSION; ENDOCYTOSIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MULTIDRUG RESISTANCE; STATIC ELECTRICITY; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECT; DRUG RESISTANCE; PARTICLE SIZE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CATIONS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EMULSIONS; FLOW CYTOMETRY; HUMANS; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; P-GLYCOPROTEIN; PARTICLE SIZE;

EID: 79955113100     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0251     Document Type: Article

References (37)

1. Barraud L, Merle P, Soma E, Lefrancois L, Guerret S, Chevallier M, Dubernet C, Couvreur P, Trepo C, Vitvitski L (2005) Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepatol 42: 736-743.
2. Batrakova EV, Li S, Miller DW, Kabanov AV (1999) Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm Res 16: 1366-1372. (Pubitemid 29449372)
3. Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA, Kruh GD (1995) Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res 55: 5342-5347.
4. Chan HS, Haddad G, Zheng L, Bradley G, Dalton WS, Ling V (1997) Sensitive immunofluorescence detection of the expression of P-glycoprotein in malignant cells. Cytometry 29: 65-75. (Pubitemid 27397799)
5. Chavanpatil MD, Patil Y, Panyam J (2006) Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Int J Pharm 320: 150-156. (Pubitemid 44128700)
6. Dabholkar RD, Sawant RM, Mongayt DA, Devarajan PV, Torchilin VP (2006) Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm 315: 148-157. (Pubitemid 43674120)
7. Deffie AM, Batra JK, Goldenberg GJ (1989) Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines. Cancer Res 49: 58-62. (Pubitemid 19024407)
8. Gabr A, Kuin A, Aalders M, El-Gawly H, Smets LA (1997) Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH. Cancer Res 57: 4811-4816. (Pubitemid 27468988)
9. Garcion E, Lamprech, A, Heurtault B, Paillard A, Aubert-Pouessel A, Denizot B, Menei P, Benoit JP (2006) A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 5: 1710-1722. (Pubitemid 44323239)
10. Gatouillat G, Odot J, Balasse E, Nicolau C, Tosi PF, Madoulet C (2007) Immunization with liposome-anchored pegylated peptides modulates doxorubicin sensitivity in P-glycoprotein-expressing P388 cells. Cancer Lett 257:165-171. (Pubitemid 47554472)
11. Goldstein D, Sader O, Benita S (2007) Influence of oil droplet surface charge on the performance of antibody-emulsion conjugates. Biomed Pharmacother 61: 97-103. (Pubitemid 46185871)
12. Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58. (Pubitemid 37328807)
13. Kirkin V, Joos S, Zornig M (2004) The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 1644: 229-249. (Pubitemid 38281277)
14. Klang SH, Frucht-Pery J, Hoffman A, Benita S (1994) Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle. J Pharm Pharmacol 46: 986-993.
15. Krishna R, MayerLD(1999) The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR). Anticancer Res 19: 2885-2891.
16. Krishnamachary N, Center MS (1993) The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 53: 3658-3661. (Pubitemid 23252019)
17. Lee ES, Na K, Bae YH (2005) Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release 103: 405-418. (Pubitemid 40342538)
18. Lucci A, Han TY, Liu YY, Giuliano AE, Cabot MC (1999) Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics. Int J Oncol 15: 541-546.
19. Lundberg BB, Risovic V, Ramaswamy M, Wasan KM (2003) A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J Control Release 86: 93-100. (Pubitemid 35461976)
20. Mayer LD, Shabbits JA (2001) The role for liposomal drug delivery in molecular and pharmacological strategies to overcome multidrug resistance. Cancer Metastasis Rev 20: 87-93. (Pubitemid 34074683)
21. Na K (2007) pH-sensitive polymeric micelles for the effective delivery of anti-cancer drug. Korean J Gastroenterol 49: 314-319.
22. Nielsen HM, Aemisegger C, Burmeister G, Schuchter U, Gander B (2004) Effect of oil-in-water emulsions on 5-aminolevulinic acid uptake and metabolism to PpIX in cultured MCF-7 cells. Pharm Res 21: 2253-2260. (Pubitemid 40568439)
23. Nobili S, Landini I, Giglioni B, Mini E (2006) Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets 7: 861-879.
24. Seid CA, Fidler IJ, Clyne RK, Earnest LE, Fan D (1991) Overcoming murine tumor cell resistance to vinblastine by presentation of the drug in multilamellar liposomes consisting of phosphatidylcholine and phosphatidylserine. Sel Cancer Ther 7: 103-112.
25. Shabbits JA, Mayer LD (2003) Intracellular delivery of ceramide lipids via liposomes enhances apoptosis in vitro. Biochim Biophys Acta 1612: 98-106. (Pubitemid 36555692)
26. Shabbits JA, Krishna R, Mayer LD (2001) Molecular and pharmacological strategies to overcome multidrug resistance. Expert Rev Anticancer Ther 1: 585-594. (Pubitemid 34685466)
27. Shi CY, Benita S (2000) Enhanced absorption and drug targeting by positively charged submicron emulsions. Drug Dev Res 50: 476-486.
28. Soma CE, Dubernet C, Bentolila D, Benita S, Couvreur P (2000) Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. Biomaterials 21: 1-7.
29. Sonawane ND, Szoka FC Jr, Verkman AS (2003) Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 278: 44826-4431.
30. Thierry AR, Vige D, Coughlin SS, Belli JA, Dritschilo A, Rahman A (1993) Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes. Faseb J 7: 572-579. (Pubitemid 23120905)
31. Vauthier C, Dubernet C, Chauvierre C, Brigger I, Couvreur P (2003) Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J Control Release 93: 151-160. (Pubitemid 37421357)
32. Viktorsson K, De Petris L, Lewensohn R (2005) The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun 331: 868-880. (Pubitemid 40615518)
33. Zelphati O, Szoka FC Jr (1996a) Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci U S A 93: 11493-11498. (Pubitemid 26347149)
34. Zelphati O, Szoka FC Jr (1996b) Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm Res 13: 1367-1372. (Pubitemid 26344983)
35. Zhang K Mack P, Wong KP (1998) Glutathione-related mechanisms in cellular resistance to anticancer drugs. Int J Oncol 12: 871-882.
36. Zhao YX, Gao JQ, Qiao HL, Chen HL, Liang WQ (2006) Development and validation of a sensitive reversed-phase HPLC method to determine intracellular accumulation of hydroxycamptothecin. J Pharm Biomed Anal 41: 1007-1010.
37. Zhao YX, Gao JQ, Sun XY, Chen HL, Wu LM, Liang WQ (2007) Enhanced nuclear delivery and cytotoxic activity of hydroxycamptothecin using o/w emulsions. J Pharm Pharm Sci 10: 61-70.